x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001137
| Product Information | |
|---|---|
| Product Name | Human IL-15 ELISA Kit |
| Species | Human |
| Description | Human IL-15 ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of IL-15 protein in cell culture extracts, cell culture supernatant, cit plasma, edta plasma, hep plasma, serum, and tissue extracts. It uses our proprietary ELISA technology. Quantitate Human IL-15 with 1.1 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Cell Culture Supernatant, Serum, Cell Culture Extracts, Tissue Extracts, Hep Plasma, Edta Plasma, Cit Plasma |
| Detection Range | 3.9 pg/mL - 250 pg/mL |
| Sensitivity | 1.1 pg/mL |
| Target Information | |
|---|---|
| Target Name | IL15 |
| UniProt No. | P40933 |
| Gene ID | 3600 |
| Target Description | Cytokine that stimulates the proliferation of T-lymphocytes. Stimulation by IL-15 requires interaction of IL-15 with components of IL-2R, including IL-2R beta and probably IL-2R gamma but not IL-2R alpha. |
| Alternative Names | IL 15; IL-15; IL15; IL15_HUMAN; Interleukin 15; Interleukin-15; Interleukin15; MGC9721 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
